Ancora Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.21K Sell
600
-76
-11% -$1.09K ﹤0.01% 1493
2026
Q1
$9.71K Buy
676
+600
+789% +$8.91K ﹤0.01% 1784
2025
Q4
$1.14K Hold
76
﹤0.01% 2222
2025
Q3
$1.1K Hold
76
﹤0.01% 1762
2025
Q2
$1.08K Hold
76
﹤0.01% 1736
2025
Q1
$1.13K Hold
76
﹤0.01% 1572
2024
Q4
$1.09K Hold
76
﹤0.01% 1628
2024
Q3
$1.2K Sell
76
-5,009
-99% -$79K ﹤0.01% 1591
2024
Q2
$78.1K Buy
5,085
+5,000
+5,882% +$75.8K ﹤0.01% 857
2024
Q1
$1.39K Hold
85
﹤0.01% 1597
2023
Q4
$1.25K Hold
85
﹤0.01% 1526
2023
Q3
$1.23K Hold
85
﹤0.01% 1546
2023
Q2
$1.4K Hold
85
﹤0.01% 1525
2023
Q1
$1.42K Buy
+85
New +$1.37K ﹤0.01% 1579

Other funds holding BMEZ

Ancora Advisors's BMEZ Position: Q2 2026 in Review

Ancora Advisors reduced its BlackRock Health Sciences Trust II (BMEZ) stake by 11% in Q2 2026, selling an estimated $1.09K and leaving 600 shares worth $9.21K. The position accounts for ﹤0.01% of the portfolio, ranked #1493.

Ancora Advisors first reported a position in BMEZ in Q1 2023 and has held it in 14 quarters since. The position peaked at $78.1K in Q2 2024. 89 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • Ancora Advisors held 600 shares of BlackRock Health Sciences Trust II worth $9.21K as of Q2 2026.
  • Ancora Advisors sold 76 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $1.09K.
  • BlackRock Health Sciences Trust II made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #1493 holding.
  • Ancora Advisors first reported a position in BlackRock Health Sciences Trust II in Q1 2023 and has held it in 14 quarters since.
  • Ancora Advisors's BlackRock Health Sciences Trust II position peaked at $78.1K in Q2 2024.
  • 89 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.